Investigating brain changes in a mouse model of Alzheimer's disease
Multimodal ventral tegmental area decrements in a mouse Alzheimer's model
This study is looking at how Alzheimer's disease impacts certain parts of the brain that help with memory and emotions, using mice that have similar brain changes to humans with Alzheimer's, to better understand why people with the disease may struggle with thinking and feel down or uninterested, which could help find new ways to treat it.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10898764 on NIH RePORTER |
What this research studies
This research explores how Alzheimer's disease affects specific brain areas, particularly the ventral tegmental area, which is important for memory and emotional regulation. Using a mouse model that mimics human Alzheimer's pathology, the study aims to understand the mechanisms behind cognitive decline and associated non-cognitive symptoms like depression and apathy. By examining different age groups of these mice, researchers hope to uncover how these brain changes contribute to the overall progression of the disease. The findings could lead to new insights into potential therapeutic targets for Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with early-stage Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with advanced Alzheimer's disease or those without any cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for Alzheimer's disease and its related symptoms.
How similar studies have performed: Previous studies have shown promising results in understanding brain changes in Alzheimer's models, indicating that this approach has potential for significant findings.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Blankenship, Harris — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Blankenship, Harris
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.